After receiving FDA clearance to use its digital stethoscope to detect heart rhythm abnormalities, startup Eko plans to build a suite of telehealth tools around its connected devices. The Berkeley, Calif.-based company, which designed a combination stethoscope and electrocardiogram (ECG), raised a $65 million series C round.
Eko plans to use the funds to expand its new telehealth platform and algorithm to more clinics, and launch an at-home monitoring program for cardiopulmonary patients.
Read more at MedCity News